RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The wellness world is eager for RFK Jr.'s promised move on peptides : NPR